Zdrowie i gospodarka · 02/06/2025

FDA Classifies Device to Detect Bacterial Protease Activity in Chronic Wound Fluid into Class II (Special Controls)

The FDA has classified a device to detect bacterial protease activity in chronic wound fluid into Class II, special controls, aiming to provide a reasonable assurance of safety and effectiveness while reducing regulatory burdens and enhancing patients' access to innovative devices.